Named on 6 rounds in the feed, most often at Series C.
Rounds from 2021-06-16 to 2026-09-16
ROUNDS
6
joined, none as lead
ROUND SIZES · USD
$484.5M
across 6 rounds
CO-INVESTORS
33
most often with Nextech Invest
Named on 6 rounds in the feed, most often at Series C.
Rounds from 2021-06-16 to 2026-09-16
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Circle Pharma A biopharmaceutical company advancing CID-165 for ER-positive breast cancer | Series E Verified against 5 sources | $92.5M | 2026-09-16 | [ PART ] |
Thatch A healthcare system | Series C Verified against 4 sources | $108M | 2026-09-15 | [ PART ] |
Remedium Bio, Inc. A biotechnology company developing durable protein therapeutics | Series A Verified against 3 sources | $10M | 2026-08-09 | [ PART ] |
Flare Therapeutics A biotech startup targeting transcription factors | Series C Verified against 5 sources | $85M | 2026-06-30 | [ PART ] |
Flare Therapeutics A biotech startup targeting transcription factors | Series B Published on thinner evidence, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $123M | 2023-03-22 | [ PART ] |
Circle Pharma A biopharmaceutical company advancing CID-165 for ER-positive breast cancer | Series C Published on thinner evidence, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $66M | 2021-06-16 | [ PART ] |